Junfeng Hao
Impact in
- Geriatrics and Gerontology top 5%
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
Papers in
-
- Circular RNAs in diseases 4
-
- Immune cells in cancer 4
- Psoriasis: Treatment and Pathogenesis 4
- Co-authors
- Xiaoyu Li (6 shared papers)Hua-feng Liu (4 shared papers)Tong An (2 shared papers)Shaoheng Sun (1 shared paper)Meiling Yang (1 shared paper)Meijuan Zou (1 shared paper)Gang Cheng (1 shared paper)Ran Li (1 shared paper)
- Journals
- Cell Death Discovery (4 papers)Frontiers in Oncology (3 papers)Autophagy (3 papers)Solid State Ionics (2 papers)European Journal of Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesColombia
In The Last Decade
Junfeng Hao
57 papers receiving 980 citations
Peers
Comparison fields: 5 of 101
- Geriatrics and Gerontology 42
- Cancer Research 163
- Nephrology 52
- Orthopedics and Sports Medicine 49
- Immunology 99
Countries citing papers authored by Junfeng Hao
This map shows the geographic impact of Junfeng Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfeng Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfeng Hao more than expected).
Fields of papers citing papers by Junfeng Hao
This network shows the impact of papers produced by Junfeng Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfeng Hao. The network helps show where Junfeng Hao may publish in the future.
Co-authors
The 25 scholars most cited alongside Junfeng Hao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 122 | |
| 2 | 2018 | 58 | |
| 3 | 2023 | 57 | |
| 4 | 2024 | 46 | |
| 5 | 2022 | 46 | |
| 6 | 2019 | 41 | |
| 7 | 2015 | 41 | |
| 8 | 2023 | 35 | |
| 9 | 2022 | 32 | |
| 10 | 2015 | 32 | |
| 11 | 2023 | 31 | |
| 12 | 2016 | 31 | |
| 13 | 2024 | 27 | |
| 14 | 2014 | 25 | |
| 15 | 2019 | 24 | |
| 16 | 2021 | 21 | |
| 17 | 2022 | 19 | |
| 18 | 2016 | 18 | |
| 19 | 2016 | 17 | |
| 20 | 2017 | 16 |
About Junfeng Hao
Junfeng Hao is a scholar working on Molecular Biology, Immunology, Surgery, Cancer Research and Epidemiology, having authored 63 papers that have together received 999 indexed citations. Recurring topics across this work include Immune cells in cancer (4 papers), Psoriasis: Treatment and Pathogenesis (4 papers), Advancements in Battery Materials (4 papers), Autophagy in Disease and Therapy (4 papers), Circular RNAs in diseases (4 papers), Advanced Battery Materials and Technologies (4 papers), Diabetes Treatment and Management (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Geriatrics and Gerontology (42 citations), Cancer Research (163 citations), Nephrology (52 citations), Orthopedics and Sports Medicine (49 citations) and Immunology (99 citations). Junfeng Hao has collaborated with scholars based in China, United States and Colombia. Frequent co-authors include Xiaoyu Li, Hua-feng Liu, Tong An, Shaoheng Sun, Meiling Yang, Meijuan Zou, Gang Cheng, Ran Li, Yongming Chen and Hui-Xia Chen. Their work appears in journals such as Cell Death Discovery, Frontiers in Oncology, Autophagy, Solid State Ionics and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.